Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: New findings connect ribosome stress biology with blood-based small RNA biomarkers, highlighting the potential of liquid biopsy for lung cancer patient stratification (Image credit: 123RF)

Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer

New findings link ribosome quality control to liquid-biopsy small RNAs, enabling lung cancer stratification and therapy guidance. More...
10 Jun 2026
Image: A simple blood test could help identify which patients with head and neck cancer are most likely to benefit from immunotherapy (image credit: Adobe Stock)

Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

A blood-based cfDNA fragment test predicts pre-treatment immunotherapy response in head and neck cancer, outperforming biomarkers. More...
09 Jun 2026
Image: Roche developed a research-use PCR assay within six days of the Bundibugyo virus genome sequence being published (image credit: Adobe Stock)

New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

A new research-use PCR test detects Bundibugyo virus to support faster outbreak response. More...
08 Jun 2026
Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: Graphical abstract (Pandya T, Zagorulya M, Leung MM, et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 2026. doi:10.1016/j.cell.2026.05.005)

Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

A 14-protein blood signature predicts lung cancer risk up to five years before diagnosis, beyond smoking status. More...
05 Jun 2026
Image: New findings show that circulating tumor DNA testing can guide postoperative chemotherapy and reduce relapse in selected patients (Image credit: Shutterstock)

Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer

A ctDNA blood test guides adjuvant chemotherapy in stage II colon cancer and cuts relapse risk. More...
04 Jun 2026
Image: In ALT-positive cancers, researchers found that centromere-associated DNA can be inserted near telomeres at chromosome ends (Image credit: Shutterstock)

Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

New findings reveal a previously unseen chromosome interaction in alternative lengthening of telomeres positive (ALT+) tumors More...
04 Jun 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.